Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
Yonsei Medical Journal
; : 679-681, 2017.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-124970
Responsible library:
WPRO
ABSTRACT
No abstract available.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Kidney Transplantation
/
Kidney
/
Antibodies
Language:
English
Journal:
Yonsei Medical Journal
Year:
2017
Document type:
Article